Catalent Pharma Solutions broke ground for a new $34 million expansion to its Madison, WI biologics manufacturing facility. When completed, the additional 22,000 sq.-ft. of space will accommodate a new 2 x 2,000 liter single-use bioreactor system, allowing the company to support late-phase clinical and commercial production of up to 4,000 liter batches. The new footprint will also support expansion of analytical and process development labs, as well as additional office space.   The Wisconsin ...